Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BioCryst Pharmaceuticals, Inc.”

65 pharma patents match "BioCryst Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 65
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 65 pharmaceutical patents matching "BioCryst Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

65 results for “BioCryst Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 11110092

    Methods of treating hematologic cancers

    BioCryst Pharmaceuticals, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  2. US 11066360

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jul 20, 2021 · Expires Jul 15, 2041

    granted
  3. US 11021458

    Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  4. US 10933066

    Methods and compositions for treatment of Zika virus infection

    BioCryst Pharmaceuticals, Inc. · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted
  5. US 10905683

    Compositions and uses of amidine derivatives

    BioCryst Pharmaceuticals, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted
  6. US 10849883

    Benzopyrazole compounds and analogues thereof

    BioCryst Pharmaceuticals, Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted
  7. US 10759759

    Prodrugs of kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  8. US 10689346

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted
  9. US 10662160

    Crystalline salts of a plasma kallikrein inhibitor

    BioCryst Pharmaceuticals, Inc. · Granted May 26, 2020 · Expires May 21, 2040

    granted
  10. US 10633345

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  11. US 10562850

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  12. US 10512649

    Methods and compositions for treatment of zika virus infection

    BioCryst Pharmaceuticals, Inc. · Granted Dec 24, 2019 · Expires Dec 19, 2039

    granted
  13. US 10420769

    Methods and compositions for inhibition of polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  14. US 10391075

    Antiviral treatments

    BioCryst Pharmaceuticals, Inc. · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted
  15. US 10329260

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted
  16. US 10125102

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  17. US 10022375

    Methods and compositions for inhibition of polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  18. US 9770427

    Antiviral treatments

    BioCryst Pharmaceuticals, Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  19. US 9580428

    Compositions and methods for inhibiting viral polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  20. US 9499554

    Anti-influenza compositions and methods

    BioCryst Pharmaceuticals, Inc. · Granted Nov 22, 2016 · Expires Nov 17, 2036

    granted
  21. US 9492452

    Methods and compositions for inhibition of polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  22. US 8778997

    Antiviral treatments

    BioCryst Pharmaceuticals, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  23. US 8440813

    Antiviral nucleoside analogs

    BioCryst Pharmaceuticals, Inc. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  24. US 8242085

    Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer

    BioCryst Pharmaceuticals, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted